MIZUHO MEDY CO.,LTD.
4595・Standard Market・Pharmaceuticals
Governance
Company with a Board of Corporate Auditors. The Board of Directors consists of 7 directors (including 2 outside directors, an outside ratio of approximately 28.6%), and the Board of Corporate Auditors consists of 3 members (including 2 outside corporate auditors). The company has established a Risk Management Committee, a Compliance Committee, a Regular Internal Control Meeting, and an Internal Audit Office, and has also adopted an executive officer system. No nomination committee or compensation committee has been established.
Risk Management
Based on the Risk Management Regulations, the Risk Management Committee (chaired by the Representative Director and composed of full-time directors and the General Affairs Department) is held regularly twice a year, and the emergence or escalation of new risks is confirmed based on the "Risk Identification Report" from each department. A system has been established whereby the Internal Audit Office audits the risk management status of each department and reports the results directly to the Representative Director and President.
Shareholder Returns
Continuing semi-annual dividends (¥50 interim, ¥50 year-end), maintaining the projected annual dividend of ¥100 for FY2026 (ending December 2026). The payout ratio based on full-year earnings guidance is approximately 59.2%. No mention of share buybacks in this financial results report.
Dividend Policy
Dividends are paid twice a year, an interim dividend (at the end of Q2) and a year-end dividend. Actual results for FY2025 (ended December 2025) were ¥100 annually (¥50 interim + ¥50 year-end). The forecast for FY2026 (ending December 2026) is also unchanged at ¥100 annually (¥50 interim + ¥50 year-end). Against full-year net income guidance of ¥3,220 million and earnings per share of ¥169.09, the payout ratio is approximately 59.1%.
ESG
A "Sustainability Promotion Secretariat" has been established within the General Affairs Department, and a system for regular reporting to the Board of Directors has been put in place. In terms of human capital, the company discloses actual results including a 100% childcare leave utilization rate for women, an 81.0% paid leave utilization rate (target: 85% or above), and a 100% retention rate, and sets targets of a childcare leave utilization rate of 50% or more for men and 14 days or more of paid leave taken. No quantitative disclosure regarding climate change is confirmed in the Annual Securities Report.
Last updated: March 26, 2026